Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Kenneth Ataga, MD
Researcher Director
Division of Hematology/Oncology
University of Tennessee Health Science Center
956 Court Avenue
D324 Coleman Building
Memphis, Tennessee, United States
Dr. Ataga’s clinical interest is in classical hematology and hemoglobinopathies. He is the Director of the Center for Sickle Cell Disease at the University of Tennessee Health Science Center (UTHSC) at Memphis. His clinical research is focused on the vasculopathy of sickle cell disease, with an emphasis on pulmonary hypertension and renal complications, and coagulation activation in sickle cell disease. In addition, Dr. Ataga has a strong research interest in the development of new therapies for sickle cell disease. He conducts clinical trials in sickle cell disease funded by the National Institutes of Health and the Pharmaceutical Industry.
Representative Publications:
Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease
Pharmacologic Therapies for Sickle Cell Disease
Related Content
-
Episodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease PatientsBackground: High utilization of emergenc...
-
Alecia Nero, MDA hematology specialist at UT Southweste...
-
Diggs-Kraus Sickle Cell CenterThe Diggs-Kraus Sickle Cell Center at Re...
-
The University of North Carolina Comprehensive Sickle Cell ProgramTo carry out basic, translational and cl...
-
I Have Sickle Cell Disease. What Should I Know About Going Away to College?When it comes to taking care of yourself...
-
Sickle Cell Disease Association of North TexasSCDA Tarrant is committed to providing m...
-
Susan Claster, MDDr. Claster graduated from the Universit...